Research: KIREMIDJIAN-SCHUMACHER an

Listed in Issue 73

Abstract

KIREMIDJIAN-SCHUMACHER and ROY, Division of Biological Sciences, Medicine and Surgery, New York University College of Dentistry, New York, NY 10010, USA, lk2@nyu.edu, reviewed (30 references) evidence that Se supplementation enhances immune responsiveness during conventional treatment of tumours and the possible additional role of immunotherapy with interleukin-2 (IL-2) in preventing tumour recurrence.

Background

Methodology

Results

Conclusion

References

Kiremidjian-Schumacher L, Roy M. Effect of selenium on the immunocompetence of patients with head and neck cancer and on adoptive immunotherapy of early and established lesions. BioFactors 14 (1-4): 161-8. 2001.

ICAN 2024 Skyscraper

Scientific and Medical Network 2

Cycle Around the World for Charity 2023

Climb Mount Kilimanjaro Charity 2023

top of the page